Seventh Sense Biosystems raises $16 mln in Series B funding

Seventh Sense Biosystems, which develops blood collection and diagnostic platforms, has raised $16 million in Series B funding from a group of investors. New investors in the funding were the venture capital arm of Siemens Financial Services, Novartis and Laboratory Corporation of America Holdings. Existing investors Flagship Ventures and Polaris Partners also participated in the funding round.

LabCorp Denies Takeover Rumors

Laboratory Corporation of America Holdings said Wednesday that it has “no knowledge” pf plans by private equity firms to take over the company via an LBO. LabCorp said in a statement that it is not in current discussions with any firms. LabCorp is responding to a Mergermarket report that says a PE consortium plans to […]

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget